Andreas Calatzis: Hidden Differences in Anti-Xa Testing
Andreas Calatzis, Managing Director of Eonis GmbH and Dynabyte GmbH, shared Stago‘s post on LinkedIn, adding:
“Interesting post.
It is indeed very good that not all anti-Xa tests contain dextran sulfate (Stago and Technoclone do not, while Werfen, Hyphen and Siemens do).”
Stago shared a post on LinkedIn:
“Dextran sulfate, a small ingredient with a big impact on Anti‑Xa results
Let’s talk about the key factor behind major Anti‑Xa variability dextran sulfate (DS)
Some Anti‑Xa reagents include DS to dissociate heparin-protein complexes in the tube.
It means that two Anti‑Xa reagents can give two different stories – only one reflects the patient.
The critical issue is that dextran sulfate:
- Does not reflect physiological conditions.
- Can cause major overestimation.
- May change clinical decisions.
Knowing what’s inside your reagent is essential for reliable heparin monitoring.
We will be at ISTH2026, in Paris!
Find out more information on booth 703 and take part to our Meet the Experts session on Sunday 12/07 – 4:00 to 4:30 PM with Pr. Corinne Frere on: Can you trust your Anti-Xa results?”
Title: Reassessment of dextran sulfate in anti-Xa assay for unfractionated heparin laboratory monitoring
Authors: Michael Hardy, Julien Cabo, Antoine Deliège, Jonathan Douxfils, Isabelle Gouin-Thibault, Thomas Lecompte, François Mullier

Title: Factors Influencing Anti-Xa Assays: A Multicenter Prospective Study in Critically Ill and Noncritically Ill Patients Receiving Unfractionated Heparin
Authors: Dominique Lasne, Marie Toussaint-Hacquard, Céline Delassasseigne, Anne Bauters, Claire Flaujac, Philippe Savard, Christine Mouton, Emmanuel De Maistre, Alain Stepanian, Valérie Eschwège, Maxime Delrue, Jean-Louis Georges, Antoine Gros, Alexandre Mansour, Guillaume Leroy, Romain Jouffroy, Matthieu Mattei, Antoine Beurton, Adeline Pontis, Marie Neuwirth, Fabienne Nedelec-Gac, Thomas Lecompte, Emmanuel Curis, Virginie Siguret, Isabelle Gouin-Thibault

Title: Monitoring unfractionated heparin in ECMO and cardiac surgery: the search for a valid reference standard
Authors: Christian F. Weber, Kai Zacharowski, Andreas Calatzis, Marie L. Lindner

Stay updated on all scientific advances with Hemostasis Today.
-
Nov 17, 2026, 10:41Elena Petkovic։ Highlights from the ISBT–WHO Plasma Management Workshop
-
Nov 17, 2026, 10:30Cheng-Hock Toh: Haematology Is Everywhere – But Is It Recognised?
-
Nov 17, 2026, 10:23Akshat Jain: The Importance of Knowing Your Sickle Cell Status
-
Nov 17, 2026, 10:12Caitlin Raymond: What Does Apheresis Really Cost?
-
Nov 17, 2026, 05:47Multidisciplinary Teams Kick Off SAHF MASAC ES 2026 with Pre-Symposium Workshops – South African Haemophilia Foundation
-
Nov 17, 2026, 05:41Boitumelo Malatji: South African Delegation Advances Advocacy Strategies at NNHF Southern Africa Workshop
-
Nov 17, 2026, 05:36Joining the PACTA Uganda Mental Health and Addiction Community Camp 2026 – Tackle Sickle Cell Africa
-
Nov 17, 2026, 05:30Nathan Connell: Women’s Hematology Summit 2027 to Address Hematologic Health Across the Lifespan
-
Nov 17, 2026, 05:25Mane Kurghinyan: Representing Armenia and HemAI Dynamics at the Falling Walls Lab Global Finale 2026